Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30285558

Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Oct 4
First author
Huntington SF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Apr 1;37(10):852-853. doi: 10.1200/JCO.18.01830.
    note
    Source null
    related pmid
    30742560
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Apr 1;37(10):853-854. doi: 10.1200/JCO.18.02297.
    note
    Source null
    related pmid
    30742563
    relationship
    Comment in

Authors and identifiers

  1. name
    Huntington SF
    type
    Author
  2. name
    von Keudell G
    type
    Author
  3. name
    Davidoff AJ
    type
    Author
  4. name
    Gross CP
    type
    Author
  5. name
    Prasad SA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Huntington SF
    type
    Author
  2. name
    von Keudell G
    type
    Author
  3. name
    Davidoff AJ
    type
    Author
  4. name
    Gross CP
    type
    Author
  5. name
    Prasad SA
    type
    Author
bibliography ids
  1. nci-bib-3c69f69ef208b45e1b8ababe
book metadata
content sha256
8f877dbe77721da11f0aee75b5ce065041f5380ace581a7b4f943ff2ffe5725d
document type
citation
dois
  1. 10.1200/JCO.18.00122
electronic publication date
display
2018 Oct 4
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30285558
immutable id
pubmed:30285558@8f877dbe77721da11f0aee75b5ce065041f5380ace581a7b4f943ff2ffe5725d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
JCO1800122
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Apr 1;37(10):852-853. doi: 10.1200/JCO.18.01830.
    note
    Source null
    related pmid
    30742560
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Apr 1;37(10):853-854. doi: 10.1200/JCO.18.02297.
    note
    Source null
    related pmid
    30742563
    relationship
    Comment in
outcomes validated
false
pmid
30285558
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
c27be0c00c063776e8280578c1c02b94abc5e40cf03c5c7b35b2aebf425b53e5
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Oct 4
precision
day
year
2018
publication types
  1. Journal Article
record status
PubMed - as supplied by publisher
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30285558/
title
Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.

Preserved source evidence · Not medical advice